Nicole Murphy

Head of Pharm Ops and Tech · 2 filings · Latest: Feb 12, 2026

BIOGEN INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
BIIB	Nicole Murphy	Head of Pharm Ops and Tech	Feb 12, 2026	Purchase	$195.04	3	$585	19,611.041	Feb 18 1:16 AM
BIIB	Nicole Murphy	Head of Pharm Ops and Tech	Feb 6, 2026	Option Exercise	$0.00	8,725	—	21,016.041	Feb 10 10:03 PM